Skip to Main Content

Author Details

Maria Martinez-Lage
Massachusetts General Hospital
1960
94
38
PMIDPaper TitleJournal TitlePublished Year
37317818When a dermatopathologist encounters the ultra-rare: A case series of superficial soft tissue/cutaneous myxopapillary ependymomas.J Cutan Pathol2024
37317818When a dermatopathologist encounters the ultra-rare: A case series of superficial soft tissue/cutaneous myxopapillary ependymomas.J Cutan Pathol2024
36288512Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations.J Clin Oncol2023
36288512Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations.J Clin Oncol2023
36271929Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1.Acta Neuropathol2023
37693537Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy.bioRxiv2023
37402650Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.Neuro Oncol2023
36960710A Comprehensive Study on the Diagnosis and Management of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.Thyroid2023
37693537Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy.bioRxiv2023
37402650Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.Neuro Oncol2023
36960710A Comprehensive Study on the Diagnosis and Management of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.Thyroid2023
36271929Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1.Acta Neuropathol2023
35445932Reimagining the Clinical Competency Committee to Enhance Education and Prepare for Competency-Based Time-Variable Advancement.J Gen Intern Med2022
35457138Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma.Int J Mol Sci2022
35706413Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition.Cancer Immunol Res2022
35445932Reimagining the Clinical Competency Committee to Enhance Education and Prepare for Competency-Based Time-Variable Advancement.J Gen Intern Med2022
35852437Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.Oncologist2022
35706413Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition.Cancer Immunol Res2022
35852437Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.Oncologist2022
35457138Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma.Int J Mol Sci2022
33290509A Simplified Brain Blocking Protocol Optimized for the Diagnosis of Neurodegenerative Disease Saves Time and Money While Preserving Anatomic Relationships.Arch Pathol Lab Med2021
35415223Recurrent Acromegaly in a Patient With a <i>CHEK2</i> Mutation.AACE Clin Case Rep2021
33967180Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot Mutations.Neurol Med Chir (Tokyo)2021
34281989Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.J Immunother Cancer2021
33735913A rapid genotyping panel for detection of primary central nervous system lymphoma.Blood2021
34041811Mosaicism for Receptor Tyrosine Kinase Activation in a Glioblastoma Involving Both PDGFRA Amplification and NTRK2 Fusion.Oncologist2021
33360262Fatal neurotoxicity after chimeric antigen receptor T-cell therapy: An unexpected case of fludarabine-associated progressive leukoencephalopathy.Eur J Cancer2021
33290509A Simplified Brain Blocking Protocol Optimized for the Diagnosis of Neurodegenerative Disease Saves Time and Money While Preserving Anatomic Relationships.Arch Pathol Lab Med2021
33402525Unilateral Relapsing Primary Angiitis of the CNS: An Entity Suggesting Differences in the Immune Response Between the Cerebral Hemispheres.Neurol Neuroimmunol Neuroinflamm2021
34452974Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis.Neurol Neuroimmunol Neuroinflamm2021
35415223Recurrent Acromegaly in a Patient With a <i>CHEK2</i> Mutation.AACE Clin Case Rep2021
33735913A rapid genotyping panel for detection of primary central nervous system lymphoma.Blood2021
34452974Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis.Neurol Neuroimmunol Neuroinflamm2021
33967180Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot Mutations.Neurol Med Chir (Tokyo)2021
34041811Mosaicism for Receptor Tyrosine Kinase Activation in a Glioblastoma Involving Both PDGFRA Amplification and NTRK2 Fusion.Oncologist2021
34281989Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.J Immunother Cancer2021
33402525Unilateral Relapsing Primary Angiitis of the CNS: An Entity Suggesting Differences in the Immune Response Between the Cerebral Hemispheres.Neurol Neuroimmunol Neuroinflamm2021
33360262Fatal neurotoxicity after chimeric antigen receptor T-cell therapy: An unexpected case of fludarabine-associated progressive leukoencephalopathy.Eur J Cancer2021
32129893Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma.Cancer2020
32028452Episodic Visual Distortions and Stroke-Like Symptoms in a 56-Year-Old Man With Intravascular Lymphoma.J Neuroophthalmol2020
32129893Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma.Cancer2020
32488924Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis.Oncologist2020
32028452Episodic Visual Distortions and Stroke-Like Symptoms in a 56-Year-Old Man With Intravascular Lymphoma.J Neuroophthalmol2020
32488924Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis.Oncologist2020
30481321A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas.Neurosurgery2019
31815646Immune landscapes associated with different glioblastoma molecular subtypes.Acta Neuropathol Commun2019
30496526Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.Neuro Oncol2019
30488294Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.J Neurooncol2019
30481321A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas.Neurosurgery2019
31173106Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases.Neuro Oncol2019
  • 1 - 50 of 188

Recommended Authors

University Health Network, University of Toronto
Career Start Year 2013
Number of shared co-authors 5
Toronto Western Hospital, University Health Network, University of Toronto
Career Start Year 2010
Number of shared co-authors 12
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2008
Number of shared co-authors 12
Medical University of Vienna
Career Start Year 2008
Number of shared co-authors 6
McGovern Medical School at UT Health Houston
Career Start Year 2007
Number of shared co-authors 3
NewYork-Presbyterian Hospital - Weill Cornell Medicine
Career Start Year 2004
Number of shared co-authors 4
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 0
University of California san francisco
Career Start Year 2001
Number of shared co-authors 10
Karl Landsteiner University of Health Sciences
Career Start Year 1999
Number of shared co-authors 5
Johns Hopkins University
Career Start Year 1998
Number of shared co-authors 10
Brigham and Women's Hospital
Career Start Year 1998
Number of shared co-authors 1
Universitatsspital Basel
Career Start Year 1996
Number of shared co-authors 13
Case Western Reverse University School of Medicine
Career Start Year 1996
Number of shared co-authors 1
Medical University of Vienna
Career Start Year 1992
Number of shared co-authors 4
Rhode Island Hospital
Career Start Year 1992
Number of shared co-authors 4
McMaster University
Career Start Year 1991
Number of shared co-authors 1
Medical University of Innsbruck
Career Start Year 1990
Number of shared co-authors 2
UCL Queen Square Institute of Neurology
Career Start Year 1989
Number of shared co-authors 12
Fondazione IRCCS Istituto Neurologico Carlo Besta
Career Start Year 1988
Number of shared co-authors 1
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1988
Number of shared co-authors 15
Akron Children's Hospital
Career Start Year 1988
Number of shared co-authors 1
Chinese University of Hong Kong
Career Start Year 1987
Number of shared co-authors 15
Children's Memorial Health Institute
Career Start Year 1987
Number of shared co-authors 13
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 8
McMaster University
Career Start Year 1986
Number of shared co-authors 1
University of Toronto
Career Start Year 1984
Number of shared co-authors 4
Hospital for Sick Children
Career Start Year 1984
Number of shared co-authors 13
University of Wisconsin School of Medicine and Public Health
Career Start Year 1980
Number of shared co-authors 5
MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 17
New York Presbyterian Hospital, Columbia University Medical Center
Career Start Year 1959
Number of shared co-authors 8

Collaborators

Co-authored papers 13
University of Pennsylvania
Co-authored papers 11
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Co-authored papers 10
Perelman School of Medicine at the University of Pennsylvania
Co-authored papers 9
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 8
University of Pennsylvania
Co-authored papers 6
Brigham and Women's Hospital
Co-authored papers 6
Massachusetts General Hospital
Co-authored papers 6
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 5
Children's Hospital of Philadelphia
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
University of California Los Angeles
Co-authored papers 4
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 4
Weill Cornell Medical College
Co-authored papers 4
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 4
Co-authored papers 4
Harvard Medical School
Co-authored papers 3
Co-authored papers 3
The Wistar Institute
Co-authored papers 3
Co-authored papers 3
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 3
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 3
University of Washington School of Medicine
Co-authored papers 3
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 3
Co-authored papers 3
Harvard Medical School
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Foundational Immunology, AbbVie Cambridge Research Center
Co-authored papers 3